Medifast (MED) Tops Q3 EPS by 105c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.15 +0.41%
Revenue Growth %: -24.3%
Financial Fact:
Diluted earnings per share: 0.51
Today's EPS Names:
SICP, MNSB, CFFI, More
Revenue Growth %: -24.3%
Financial Fact:
Diluted earnings per share: 0.51
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q3 EPS of $2.12, $1.05 better than the analyst estimate of $1.07. Revenue for the quarter came in at $235.9 million versus the consensus estimate of $232.1 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scotiabank Names Top Utility Stocks Amid Data Center Growth
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- WhiteHorse Finance gains as Raymond James upgrades on strategic review
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
